Profilo
Yi Hong Yao is currently Chief Scientific Officer at AbelZeta Pharma, Inc. since 2015.
Formerly, Dr. Yao was Director at MedImmune LLC from 2011 to 2015.
Education includes graduate studies at Boston University, a doctorate from the University of Kansas, and undergraduate studies at Fudan University.
Posizioni attive di Yi Hong Yao
| Società | Posizione | Inizio |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2015 |
Precedenti posizioni note di Yi Hong Yao
| Società | Posizione | Fine |
|---|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direttore/Membro del Consiglio | 01/07/2015 |
Formazione di Yi Hong Yao
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Develops cell therapies to cure cancer and inflammatory & immunological diseases | Health Technology |
















